Mayne Pharma

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
  3. Roche's cancer immunotherapy Tecentriq Hybreza bags FDA approval The drug first and only subcutaneous PD-(L)1 inhibitor available for patients with certain types of lung, skin, liver and soft tissue cancers
  4. Moderna's mRNA manufacturing facility bags Canadian Drug Establishment License The Canadian facility can now domestically manufacture a range of mRNA vaccines to treat respiratory viruses
  5. Genesis Pharma to distribute Santhera's Agamree for DMD The therapeutic recently received EC approval to treat patients over 4 years old with Duchenne muscular dystrophy

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Manufacturing

Catalent to acquire Metrics to expand high-potent capabilities and oral development and manufacturing capacity

Catalent has reached an agreement to acquire Metrics Contract Services, a full-service specialty contract development and manufacturing organisation (CDMO) with a facility in Greenville (NC, US) for $475 million from Mayne Pharma Group
Manufacturing

Drug dose delivery development, manufacturing and commercialisation trends: part II

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
Manufacturing

Drug dose delivery development, manufacturing and commercialisation trends: part I

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
Manufacturing

Navigating the sea change of pharmaceutical outsourcing: part II

After what has oft-been described as an unprecedented period of turbulence in almost every aspect of our everyday lives, Dr Kevin Robinson sat down with experts from a number of pharmaceutical contract development and manufacturing organisations (CDMOs) to discuss how the events of the past year have affected the activity and outlook of the industry’s outsourcing sector
Manufacturing

Navigating the sea change of pharmaceutical outsourcing: part I

After what has oft-been described as an unprecedented period of turbulence in almost every aspect of our everyday lives, Dr Kevin Robinson sat down with experts from a number of pharmaceutical contract development and manufacturing organisations (CDMOs) to discuss how the events of the past year have affected the activity and outlook of the industry’s outsourcing sector
Subscribe now